drugset / Trial / NCT01394679
A Phase 3 Study of 99mTC-EC-DG SPECT/CT Versus PET/CT in Lung Cancer
Non-randomizedSequentialOpen-labelDiagnostic
Summary
The purpose of this study is to determine if the images of the primary lesions of lung cancer and any metastatic lesions seen from the investigational SPECT/CT 99mTC-EC-DG scans are the same as the PET/CT 18F-FDG scans.
Timeline
- Start
- 2025-05-01
- Primary completion
- 2025-12
- Completion
- 2026-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | 18F-FDG | Diagnostic / imaging agent | 370 mbq | — |
| Comparator | 18F-FDG | Diagnostic / imaging agent | 740 mbq | — |
| Subject | TECHNETIUM TC-99M ETHYLENE-DICYSTEINE-DEOXYGLUCOSE | Unknown | 1 mg | Intravenous |
| Subject | TECHNETIUM TC-99M ETHYLENE-DICYSTEINE-DEOXYGLUCOSE | Unknown | 925 mbq | Intravenous |